Delirium in intensive care unit (ICU) settings is a frequent complication with reported prevalence of 31%. Recent data has revealed the connection between delirium and increased 30days mortality after hospital release and the higher incidence of readmission to emergency. Despite the high prevalence and well described validation methods for screening, the precise incidence remains unclear due to insufficient screening in ICU settings. The incidence of delirium in Czech Republic remains undescribed, beside data reported from neurointensive care patients and single-center general critically ill patients data.
All patients fulfilling inclusion criteria in intensive care settings in involved ICUs in Czech Republic will be included into the study. Data will be recorded for 1 consequent month. Basic demography will be evaluated. In each patient standard delirium screening based on the institutional ICU rules will be performed. If no screening method were set,Confusion Assessment Method - CAM-ICU for adult and pediatric Confusion Assessment Method -pCAM-ICU for pediatric patients would be used together with delirium management, restrain procedures, sedative/neuroleptics administration, 28-days mortality. All data will be recorded into to predefined eCRF.
Study Type
OBSERVATIONAL
Enrollment
2,000
Delirium in adult patients will be screened according to CAM-ICU
Delirium in adult patients will be screened according to pCAM-ICU
Brno University Hospital
Brno, South Moravian, Czechia
Delirium prevalence
Delirium prevalence by CAM-ICU and pCAM-ICU will be screened in defined time interval
Time frame: during 30 days after study initiation in selected ICU
Delirium management
Management of delirium will be evaluated
Time frame: during 30 days after study initiation in selected ICU
Inhospital mortality
Inhospital mortality will be evaluated
Time frame: during 30 days after study initiation in selected ICU
28-days mortality
28-days mortality will be evaluated
Time frame: after patient inclusion into the study
90-days mortality
long term mortality will be evaluated
Time frame: after patient inclusion into the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.